Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001857 |
---|---|
Receipt number | R000002236 |
Scientific Title | A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen |
Date of disclosure of the study information | 2009/04/10 |
Last modified on | 2016/10/12 10:43:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/04/07 10:06:25 | ||
2 | Update | 2010/04/07 10:11:06 | Recruitment status |
|
3 | Update | 2010/08/23 13:13:27 | Recruitment status |
|
4 | Update | 2010/10/08 08:28:24 | Recruitment status |
|
5 | Update | 2012/04/08 08:53:15 | Date analysis concluded |
|
6 | Update | 2012/04/08 08:54:28 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2012/05/08 10:52:53 | Recruitment status |
|
8 | Update | 2013/04/07 09:32:13 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results Results Results |
|
9 | Update | 2013/10/07 10:16:27 | Email Homepage URL Institutions |
|
10 | Update | 2015/10/07 09:41:15 | Key inclusion criteria |
|
11 | Update | 2016/04/07 09:03:25 | Name of primary person or sponsor Institute Department Organization |
|
12 | Update | 2016/10/12 10:43:34 | Recruitment status Publication of results URL related to results and publications Results Results |